{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:31:28Z","timestamp":1793637088362,"version":"4.5.1"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s10787-025-01705-1","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T21:31:01Z","timestamp":1746135061000},"page":"2623-2640","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Biomarkers in Alzheimer\u2019s disease: new frontiers with olfactory models"],"prefix":"10.1007","volume":"33","author":[{"given":"Shubhrat","family":"Maheshwari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9224-7569","authenticated-orcid":false,"given":"Amita","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,1]]},"reference":[{"issue":"5","key":"1705_CR1","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s11011-020-00564-9","volume":"35","author":"S Ahmadi","year":"2020","unstructured":"Ahmadi S, Zobeiri M, Bradburn S (2020) Molecular mechanisms underlying actions of certain long noncoding RNAs in Alzheimer\u2019s disease. Metabol Brain Dis 35(5):681\u2013693","journal-title":"Metabol Brain Dis"},{"issue":"2","key":"1705_CR2","first-page":"419","volume":"22","author":"LG Apostolova","year":"2016","unstructured":"Apostolova LG (2016) Alzheimer disease. Contin: Lifelong Learni Neurol 22(2):419\u2013434","journal-title":"Contin: Lifelong Learni Neurol"},{"key":"1705_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/bcpt.14035","volume":"135","author":"S Arjmand","year":"2024","unstructured":"Arjmand S, Ilaghi M, Sisakht AK, Guldager MB, Wegener G, Landau AM, Gjedde A (2024) Regulation of mitochondrial dysfunction by estrogens and estrogen receptors in Alzheimer\u2019s disease: a focused review. Basic Clin Pharmacol Toxicol 135:115\u2013132","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"14","key":"1705_CR4","doi-asserted-by":"publisher","first-page":"1165594","DOI":"10.3389\/fneur.2023.1165594","volume":"2","author":"E Audronyte","year":"2023","unstructured":"Audronyte E, Sutnikiene V, Pakulaite-Kazliene G, Kaubrys G (2023) Olfactory memory in mild cognitive impairment and Alzheimer\u2019s disease. Front Neurol 2(14):1165594","journal-title":"Front Neurol"},{"issue":"2","key":"1705_CR5","first-page":"319","volume":"48","author":"M Bidzan","year":"2014","unstructured":"Bidzan M, Bidzan L (2014) Neurobehavioral manifestation in early period of Alzheimer disease and vascular dementia. Psychiatr Polska 48(2):319\u2013330","journal-title":"Psychiatr Polska"},{"issue":"14","key":"1705_CR6","doi-asserted-by":"publisher","first-page":"7893","DOI":"10.3390\/ijms25147893","volume":"25","author":"G Bivona","year":"2024","unstructured":"Bivona G, Sammataro S, Ghersi G (2024) Nucleic acids-based biomarkers for alzheimer\u2019s disease diagnosis and novel molecules to treat the disease. Int J Mol Sci 25(14):7893","journal-title":"Int J Mol Sci"},{"issue":"92","key":"1705_CR7","doi-asserted-by":"publisher","first-page":"102095","DOI":"10.1016\/j.arr.2023.102095","volume":"1","author":"AR Bothwell","year":"2023","unstructured":"Bothwell AR, Resnick SM, Ferrucci L, Tian Q (2023) Associations of olfactory function with brain structural and functional outcomes a systematic review. Ageing Res Rev 1(92):102095","journal-title":"Ageing Res Rev"},{"issue":"123","key":"1705_CR8","doi-asserted-by":"publisher","first-page":"105425","DOI":"10.1016\/j.archger.2024.105425","volume":"1","author":"J Bouhaben","year":"2024","unstructured":"Bouhaben J, Delgado-Lima AH, Delgado-Losada ML (2024) The role of olfactory dysfunction in mild cognitive impairment and Alzheimer\u2019s disease: a meta-analysis. Archiv Gerontol Geriatr 1(123):105425","journal-title":"Archiv Gerontol Geriatr"},{"issue":"10","key":"1705_CR9","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.mad.2013.08.005","volume":"134","author":"MA Bradley-Whitman","year":"2013","unstructured":"Bradley-Whitman MA, Lovell MA (2013) Epigenetic changes in the progression of Alzheimer\u2019s disease. Mech Ageing Dev 134(10):486\u2013495","journal-title":"Mech Ageing Dev"},{"issue":"145","key":"1705_CR10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/B978-0-12-802395-2.00023-7","volume":"1","author":"AL Calderon-Garcidue\u00f1as","year":"2018","unstructured":"Calderon-Garcidue\u00f1as AL, Duyckaerts C (2018) Alzheimer disease. Handbook Clin Neurol 1(145):325\u2013337","journal-title":"Handbook Clin Neurol"},{"issue":"4","key":"1705_CR11","doi-asserted-by":"publisher","first-page":"875","DOI":"10.24272\/j.issn.2095-8137.2024.183","volume":"45","author":"J Cao","year":"2024","unstructured":"Cao J, Zhang YW (2024) Targeting synaptic pathology in Alzheimer\u2019s disease. Zool Res 45(4):875","journal-title":"Zool Res"},{"key":"1705_CR12","doi-asserted-by":"publisher","first-page":"e13252","DOI":"10.1111\/bpa.13252","volume":"7","author":"P Cartas-Cejudo","year":"2024","unstructured":"Cartas-Cejudo P, Cort\u00e9s A, Lach\u00e9n-Montes M, Anaya-Cubero E, Puerta E, Solas M, Fern\u00e1ndez-Irigoyen J, Santamar\u00eda E (2024) Neuropathological stage-dependent proteome mapping of the olfactory tract in Alzheimer\u2019s disease: from early olfactory-related omics signatures to computational repurposing of drug candidates. Brain Pathol 7:e13252","journal-title":"Brain Pathol"},{"issue":"9","key":"1705_CR13","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.disamonth.2010.06.001","volume":"56","author":"RJ Castellani","year":"2010","unstructured":"Castellani RJ, Rolston RK, Smith MA (2010) Alzheimer disease. Disease-a-Month: DM 56(9):484","journal-title":"Disease-a-Month: DM"},{"issue":"1","key":"1705_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41398-023-02361-1","volume":"13","author":"P Chen","year":"2023","unstructured":"Chen P, Cai H, Bai W, Su Z, Tang YL, Ungvari GS, Ng CH, Zhang Q, Xiang YT (2023) Global prevalence of mild cognitive impairment among older adults living in nursing homes: a meta-analysis and systematic review of epidemiological surveys. Trans Psychiatr. 13(1):88","journal-title":"Trans Psychiatr."},{"key":"1705_CR15","first-page":"1","volume":"5","author":"MR Chowdhury","year":"2024","unstructured":"Chowdhury MR, Kumar V, Deepa VS (2024) Unraveling metabolic pathways and key genes in Alzheimer\u2019s, type 2 diabetes, and estrogen dysregulation among aging women: a systems biology approach. J Proteins Proteom 5:1\u20134","journal-title":"J Proteins Proteom"},{"issue":"16","key":"1705_CR16","doi-asserted-by":"publisher","first-page":"9077","DOI":"10.3390\/ijms25169077","volume":"25","author":"GL Cipriano","year":"2024","unstructured":"Cipriano GL, Mazzon E, Anchesi I (2024) Estrogen receptors: a new frontier in alzheimer\u2019s disease therapy. Int J Mol Sci 25(16):9077","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1705_CR17","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0149-7634(00)00012-9","volume":"24","author":"A Collie","year":"2000","unstructured":"Collie A, Maruff P (2000) The neuropsychology of preclinical Alzheimer\u2019s disease and mild cognitive impairment. Neurosci Biobehav Rev 24(3):365\u2013374","journal-title":"Neurosci Biobehav Rev"},{"issue":"4","key":"1705_CR18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1001\/jamaneurol.2024.0017","volume":"81","author":"AH Cross","year":"2024","unstructured":"Cross AH, Gelfand JM, Thebault S, Bennett JL, Von B\u00fcdingen HC, Cameron B, Carruthers R, Edwards K, Fallis R, Gerstein R, Giacomini PS (2024) Emerging cerebrospinal fluid biomarkers of disease activity and progression in multiple sclerosis. JAMA Neurol 81(4):373\u2013383","journal-title":"JAMA Neurol"},{"issue":"2","key":"1705_CR19","doi-asserted-by":"publisher","first-page":"e12385","DOI":"10.1002\/trc2.12385","volume":"9","author":"J Cummings","year":"2023","unstructured":"Cummings J, Zhou Y, Lee G, Zhong K, Fonseca J, Cheng F (2023) Alzheimer\u2019s disease drug development pipeline: 2023. Alzheimer\u2019s Dementia: Translat Res Clin Interv 9(2):e12385","journal-title":"Alzheimer's Dementia: Translat Res Clin Interv"},{"issue":"1","key":"1705_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13195-023-01314-6","volume":"15","author":"B Dubois","year":"2023","unstructured":"Dubois B, von Arnim CA, Burnie N, Bozeat S, Cummings J (2023) Biomarkers in Alzheimer\u2019s disease: role in early and differential diagnosis and recognition of atypical variants. Alzheimer\u2019s Res Therapy 15(1):175","journal-title":"Alzheimer's Res Therapy"},{"key":"1705_CR21","doi-asserted-by":"publisher","first-page":"2400525","DOI":"10.1002\/mnfr.202400525","volume":"58","author":"MA Elawad","year":"2024","unstructured":"Elawad MA, Ayaz M, Mosa OF, Usman A, Hamdoon AA, Almawash S, Salim LH, Ahmed A, Elkhalifa ME (2024) Polyphenols and their biogenic nano-formulations targeting bace1 as anti-amyloid therapies; meeting the challenges of bioavailability, safety, and specificity for the treatment of Alzheimer\u2019s disease. Mol Nutr Food Res 58:2400525","journal-title":"Mol Nutr Food Res"},{"issue":"18","key":"1705_CR22","doi-asserted-by":"publisher","first-page":"1503069","DOI":"10.3389\/fnins.2024.1503069","volume":"16","author":"K Elhabbari","year":"2024","unstructured":"Elhabbari K, Sireci S, Rothermel M, Brunert D (2024) Olfactory deficits in aging and Alzheimer\u2019s\u2014spotlight on inhibitory interneurons. Front Neurosci 16(18):1503069","journal-title":"Front Neurosci"},{"issue":"3","key":"1705_CR23","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.3390\/ijms24032117","volume":"24","author":"I Fatuzzo","year":"2023","unstructured":"Fatuzzo I, Niccolini GF, Zoccali F, Cavalcanti L, Bellizzi MG, Riccardi G, de Vincentiis M, Fiore M, Petrella C, Minni A, Barbato C (2023) Neurons, nose, and neurodegenerative diseases: olfactory function and cognitive impairment. Int J Mol Sci 24(3):2117","journal-title":"Int J Mol Sci"},{"key":"1705_CR24","doi-asserted-by":"publisher","first-page":"1175230","DOI":"10.3389\/fmolb.2023.1175230","volume":"10","author":"B Fazeli","year":"2023","unstructured":"Fazeli B, Huss A, de San G, Jos\u00e9 N, Otto M, Tumani H, Halbgebauer S (2023) Development of an ultrasensitive microfluidic assay for the analysis of glial fibrillary acidic protein (GFAP) in blood. Front Mol Biosci 10:1175230","journal-title":"Front Mol Biosci"},{"issue":"9","key":"1705_CR25","doi-asserted-by":"publisher","first-page":"e003200","DOI":"10.1136\/bmjopen-2013-003200","volume":"3","author":"M Fern\u00e1ndez-Mart\u00ednez","year":"2013","unstructured":"Fern\u00e1ndez-Mart\u00ednez M, Mart\u00edn XE, Mart\u00edn EB, Alcelay LG, Serrano IU, Busto FG, \u00c1lvarez-\u00c1lvarez M, Salazar AM, Gandarias RB, Borda SI, Valiente JM (2013) Oestrogen receptor polymorphisms are an associated risk factor for mild cognitive impairment and Alzheimer disease in women APOE \u025b4 carriers: a case\u2013control study. BMJ Open 3(9):e003200","journal-title":"BMJ Open"},{"issue":"101","key":"1705_CR26","doi-asserted-by":"publisher","first-page":"101273","DOI":"10.1016\/j.preteyeres.2024.101273","volume":"1","author":"BP Gaire","year":"2024","unstructured":"Gaire BP, Koronyo Y, Fuchs DT, Shi H, Rentsendorj A, Danziger R, Vit JP, Mirzaei N, Doustar J, Sheyn J, Hampel H (2024) Alzheimer\u2019s disease pathophysiology in the retina. Prog Retinal Eye Res. 1(101):101273","journal-title":"Prog Retinal Eye Res."},{"issue":"7","key":"1705_CR27","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.3390\/pharmaceutics14071354","volume":"14","author":"A Ganne","year":"2022","unstructured":"Ganne A, Balasubramaniam M, Griffin WS, Shmookler Reis RJ, Ayyadevara S (2022) Glial fibrillary acidic protein: a biomarker and drug target for alzheimer\u2019s disease. Pharmaceutics 14(7):1354","journal-title":"Pharmaceutics"},{"issue":"82","key":"1705_CR28","doi-asserted-by":"publisher","first-page":"101756","DOI":"10.1016\/j.arr.2022.101756","volume":"1","author":"M George","year":"2022","unstructured":"George M, Tharakan M, Culberson J, Reddy AP, Reddy PH (2022) Role of Nrf2 in aging, Alzheimer\u2019s and other neurodegenerative diseases. Ageing Res Rev 1(82):101756","journal-title":"Ageing Res Rev"},{"issue":"4","key":"1705_CR29","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1038\/s41380-023-01976-6","volume":"28","author":"FA Gigase","year":"2023","unstructured":"Gigase FA, Smith E, Collins B, Moore K, Snijders GJ, Katz D, Bergink V, Perez-Rodriquez MM, De Witte LD (2023) The association between inflammatory markers in blood and cerebrospinal fluid: a systematic review and meta-analysis. Mol Psychiatr 28(4):1502\u20131515","journal-title":"Mol Psychiatr"},{"issue":"5","key":"1705_CR30","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s43587-023-00403-3","volume":"3","author":"O Hansson","year":"2023","unstructured":"Hansson O, Blennow K, Zetterberg H, Dage J (2023) Blood biomarkers for Alzheimer\u2019s disease in clinical practice and trials. Nat Aging. 3(5):506\u2013519","journal-title":"Nat Aging."},{"issue":"2","key":"1705_CR31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.cels.2020.11.007","volume":"12","author":"TJ Hark","year":"2021","unstructured":"Hark TJ, Rao NR, Castillon C, Basta T, Smukowski S, Bao H, Upadhyay A, Bomba-Warczak E, Nomura T, O\u2019Toole ET, Morgan GP (2021) Pulse-chase proteomics of the App knockin mouse models of Alzheimer\u2019s disease reveals that synaptic dysfunction originates in presynaptic terminals. Cell Syst 12(2):141\u2013158","journal-title":"Cell Syst"},{"issue":"9","key":"1705_CR32","doi-asserted-by":"publisher","first-page":"e209884","DOI":"10.1212\/WNL.0000000000209884","volume":"103","author":"J Hazan","year":"2024","unstructured":"Hazan J, Liu KY, Costello H, Isaacs JD, Thambisetty M, Howard R (2024) Challenges in a biological definition of Alzheimer disease. Neurology 103(9):e209884","journal-title":"Neurology"},{"issue":"1","key":"1705_CR33","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12929-023-00976-6","volume":"30","author":"LK Huang","year":"2023","unstructured":"Huang LK, Kuan YC, Lin HW, Hu CJ (2023) Clinical trials of new drugs for Alzheimer disease: a 2020\u20132023 update. J Biomed Sci 30(1):83","journal-title":"J Biomed Sci"},{"issue":"11","key":"1705_CR34","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.3389\/fneur.2020.01054","volume":"18","author":"NA Huebschmann","year":"2020","unstructured":"Huebschmann NA, Luoto TM, Karr JE, Berghem K, Blennow K, Zetterberg H, Ashton NJ, Simr\u00e9n J, Posti JP, Gill JM, Iverson GL (2020) Comparing glial fibrillary acidic protein (GFAP) in serum and plasma following mild traumatic brain injury in older adults. Front Neurol 18(11):1054","journal-title":"Front Neurol"},{"key":"1705_CR35","first-page":"1","volume":"4","author":"TR Hunter","year":"2024","unstructured":"Hunter TR, Santos LE, Tovar-Moll F, De Felice FG (2024) Alzheimer\u2019s disease biomarkers and their current use in clinical research and practice. Mol Psychiatr 4:1\u20133","journal-title":"Mol Psychiatr"},{"issue":"5","key":"1705_CR36","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.cmet.2015.08.016","volume":"22","author":"M Ishii","year":"2015","unstructured":"Ishii M, Iadecola C (2015) Metabolic and non-cognitive manifestations of Alzheimer\u2019s disease: the hypothalamus as both culprit and target of pathology. Cell Metab 22(5):761\u2013776","journal-title":"Cell Metab"},{"issue":"6","key":"1705_CR37","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.jalz.2014.01.001","volume":"10","author":"F Jessen","year":"2014","unstructured":"Jessen F, Amariglio RE, Van Boxtel M, Breteler M, Ceccaldi M, Ch\u00e9telat G, Dubois B, Dufouil C, Ellis KA, Van Der Flier WM, Glodzik L (2014) A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer\u2019s disease. Alzheimer\u2019s Dementia 10(6):844\u2013852","journal-title":"Alzheimer's Dementia"},{"issue":"2","key":"1705_CR38","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1212\/WNL.55.2.210","volume":"55","author":"KJ Kantarci","year":"2000","unstructured":"Kantarci KJ, Jack CR Jr, Xu YC, Campeau NG, O\u2019Brien PC, Smith G, Ivnik RJ, Boeve BF, Kokmen E, Tangalos EG, Petersen RC (2000) Regional metabolic patterns in mild cognitive impairment and Alzheimer\u2019s disease: a 1H MRS study. Neurology 55(2):210\u2013217","journal-title":"Neurology"},{"key":"1705_CR39","first-page":"115134","volume":"29","author":"R Kaur","year":"2024","unstructured":"Kaur R, Pandey S, Gupta S, Singh J (2024) Harnessing the potential of long non-coding RNAs in the pathophysiology of Alzheimer\u2019s disease. Exp Neurol 29:115134","journal-title":"Exp Neurol"},{"issue":"11","key":"1705_CR40","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00018-022-04575-w","volume":"79","author":"R Keable","year":"2022","unstructured":"Keable R, Hu S, Pfundstein G, Kozlova I, Su F, Du X, Yang H, Gunnersen J, Schachner M, Leshchyns\u2019ka I, Sytnyk V (2022) The BACE1-generated C-terminal fragment of the neural cell adhesion molecule 2 (NCAM2) promotes BACE1 targeting to Rab11-positive endosomes. Cell Mol Life Sci 79(11):555","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"1705_CR41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman DS, Amieva H, Petersen RC, Ch\u00e9telat G, Holtzman DM, Hyman BT, Nixon RA, Jones DT (2021) Alzheimer disease. Nat Rev Dis Prim 7(1):33","journal-title":"Nat Rev Dis Prim"},{"issue":"4","key":"1705_CR42","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41582-024-00940-4","volume":"20","author":"AD Korczyn","year":"2024","unstructured":"Korczyn AD, Grinberg LT (2024) Is Alzheimer disease a disease? Nat Rev Neurol 20(4):245\u2013251","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"1705_CR43","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1002\/alz.12932","volume":"19","author":"EJ Laukka","year":"2023","unstructured":"Laukka EJ, Ekstr\u00f6m I, Larsson M, Grande G, Fratiglioni L, Rizzuto D (2023) Markers of olfactory dysfunction and progression to dementia: a 12-year population-based study. Alzheimer\u2019s Dementia 19(7):3019\u20133027","journal-title":"Alzheimer's Dementia"},{"key":"1705_CR44","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s12035-013-8484-9","volume":"49","author":"JH Lee","year":"2014","unstructured":"Lee JH, Jiang Y, Han DH, Shin SK, Choi WH, Lee MJ (2014) Targeting estrogen receptors for the treatment of Alzheimer\u2019s disease. Mol Neurobiol 49:39\u201349","journal-title":"Mol Neurobiol"},{"issue":"6","key":"1705_CR45","doi-asserted-by":"publisher","first-page":"fcae396","DOI":"10.1093\/braincomms\/fcae396","volume":"6","author":"F Leipp","year":"2024","unstructured":"Leipp F, Vialaret J, Mohaupt P, Coppens S, Jaffuel A, Niehoff AC, Lehmann S, Hirtz C (2024) Glial fibrillary acidic protein in Alzheimer\u2019s disease: a narrative review. Brain Commun 6(6):fcae396","journal-title":"Brain Commun"},{"issue":"2","key":"1705_CR46","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1136\/jnnp-2016-313775","volume":"88","author":"AW Lemstra","year":"2017","unstructured":"Lemstra AW, De Beer MH, Teunissen CE, Schreuder C, Scheltens P, Van Der Flier WM, Sikkes SA (2017) Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies. J Neurol, Neurosurg Psychiatr 88(2):113\u2013118","journal-title":"J Neurol, Neurosurg Psychiatr"},{"key":"1705_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12867-019-0140-0","volume":"20","author":"F Li","year":"2019","unstructured":"Li F, Wang Y, Yang H, Xu Y, Zhou X, Zhang X, Xie Z, Bi J (2019) The effect of BACE1-AS on \u03b2-amyloid generation by regulating BACE1 mRNA expression. BMC Mol Biol 20:1","journal-title":"BMC Mol Biol"},{"issue":"6","key":"1705_CR48","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/alz.12345","volume":"17","author":"X Li","year":"2021","unstructured":"Li X, Tsolis KC, Koper MJ, Ronisz A, Ospitalieri S, von Arnim CA, Vandenberghe R, Tousseyn T, Scheuerle A, Economou A, Carpentier S (2021) Sequence of proteome profiles in preclinical and symptomatic Alzheimer\u2019s disease. Alzheimer\u2019s Dementia 17(6):946\u2013958","journal-title":"Alzheimer's Dementia"},{"key":"1705_CR49","doi-asserted-by":"publisher","first-page":"102453","DOI":"10.1016\/j.arr.2024.102453","volume":"8","author":"W Liao","year":"2024","unstructured":"Liao W, Wang Y, Li J, Huang D, Cheng W, Luan P (2024) The current status and challenges of olfactory dysfunction study in Alzheimer\u2019s disease. Ageing Res Rev 8:102453","journal-title":"Ageing Res Rev"},{"issue":"1","key":"1705_CR50","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1186\/s12916-023-03120-1","volume":"21","author":"J Lin","year":"2023","unstructured":"Lin J, Ou R, Li C, Hou Y, Zhang L, Wei Q, Pang D, Liu K, Jiang Q, Yang T, Xiao Y (2023) Plasma glial fibrillary acidic protein as a biomarker of disease progression in Parkinson\u2019s disease: a prospective cohort study. BMC Med 21(1):420","journal-title":"BMC Med"},{"issue":"1","key":"1705_CR51","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12974-023-02843-5","volume":"20","author":"T Liu","year":"2023","unstructured":"Liu T, Zuo H, Ma D, Song D, Zhao Y, Cheng O (2023) Cerebrospinal fluid GFAP is a predictive biomarker for conversion to dementia and Alzheimer\u2019s disease-associated biomarkers alterations among de novo parkinson\u2019s disease patients: a prospective cohort study. J Neuroinflammation 20(1):167","journal-title":"J Neuroinflammation"},{"key":"1705_CR52","doi-asserted-by":"publisher","first-page":"100016","DOI":"10.1016\/j.bbii.2023.100016","volume":"11","author":"J Liu","year":"2023","unstructured":"Liu J, Shi H, Lee TM (2023) Qigong exercise and cognitive function in brain imaging studies: a systematic review of randomized controlled trials in healthy and cognitively impaired populations. Brain Behav Immun Integr. 11:100016","journal-title":"Brain Behav Immun Integr."},{"issue":"18","key":"1705_CR53","doi-asserted-by":"publisher","first-page":"1309482","DOI":"10.3389\/fnins.2024.1309482","volume":"16","author":"D Liu","year":"2024","unstructured":"Liu D, Lu J, Wei L, Yao M, Yang H, Lv P, Wang H, Zhu Y, Zhu Z, Zhang X, Chen J (2024) Olfactory deficit: a potential functional marker across the Alzheimer\u2019s disease continuum. Front Neurosci 16(18):1309482","journal-title":"Front Neurosci"},{"issue":"7","key":"1705_CR54","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1210\/en.2004-0427","volume":"145","author":"NJ MacLusky","year":"2004","unstructured":"MacLusky NJ (2004) Estrogen and Alzheimer\u2019s disease: the apolipoprotein connection. Endocrinology 145(7):3062\u20133064","journal-title":"Endocrinology"},{"issue":"4","key":"1705_CR55","first-page":"1688","volume":"20","author":"S Maheshwari","year":"2022","unstructured":"Maheshwari S, Singh A, Yadav JP, Bhadauria SS, Shukla S, Kumar A, Jain N, Jain N (2022) Advancing liposomal drug delivery in alzheimer\u2019s disease: current insights and future perspectives. NeuroQuantology 20(4):1688","journal-title":"NeuroQuantology"},{"issue":"5","key":"1705_CR56","first-page":"5593","volume":"20","author":"S Maheshwari","year":"2022","unstructured":"Maheshwari S, Singh A, Yadav JP, Kumar A, Kumar A, Jain N, Jain N (2022) Neurotrophic factor signaling in neurological disorders: implications for disease pathogenesis and therapy. NeuroQuantology. 20(5):5593","journal-title":"NeuroQuantology."},{"issue":"1","key":"1705_CR57","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3233\/JAD-131490","volume":"39","author":"M Marchese","year":"2014","unstructured":"Marchese M, Cowan D, Head E, Ma D, Karimi K, Ashthorpe V, Kapadia M, Zhao H, Davis P, Sakic B (2014) Autoimmune manifestations in the 3xTg-AD model of Alzheimer\u2019s disease. J Alzheimer\u2019s Dis 39(1):191\u2013210","journal-title":"J Alzheimer's Dis"},{"issue":"12","key":"1705_CR58","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1016\/j.neurobiolaging.2008.12.005","volume":"31","author":"D Mastroeni","year":"2010","unstructured":"Mastroeni D, Grover A, Delvaux E, Whiteside C, Coleman PD, Rogers J (2010) Epigenetic changes in Alzheimer\u2019s disease: decrements in DNA methylation. Neurobiol Aging 31(12):2025\u20132037","journal-title":"Neurobiol Aging"},{"issue":"1","key":"1705_CR59","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13041-023-01068-0","volume":"16","author":"Q Meng","year":"2023","unstructured":"Meng Q, Chao Y, Zhang S, Ding X, Feng H, Zhang C, Liu B, Zhu W, Li Y, Zhang Q, Tong H (2023) Attenuation of estrogen and its receptors in the post-menopausal stage exacerbates dyslipidemia and leads to cognitive impairment. Mol Brain 16(1):80","journal-title":"Mol Brain"},{"key":"1705_CR60","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1007\/s10787-020-00724-4","volume":"28","author":"BA Messiha","year":"2020","unstructured":"Messiha BA, Ali MR, Khattab MM, Abo-Youssef AM (2020) Perindopril ameliorates experimental Alzheimer\u2019s disease progression: role of amyloid \u03b2 degradation, central estrogen receptor and hyperlipidemic-lipid raft signaling. Inflammopharmacology 28:1343\u20131364","journal-title":"Inflammopharmacology"},{"issue":"3","key":"1705_CR61","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1007\/s12035-022-03152-3","volume":"60","author":"P Mishra","year":"2023","unstructured":"Mishra P, Davies DA, Albensi BC (2023) The interaction between nf-\u03bab and estrogen in Alzheimer\u2019s disease. Mol Neurobiol 60(3):1515\u20131526","journal-title":"Mol Neurobiol"},{"issue":"1","key":"1705_CR62","doi-asserted-by":"publisher","first-page":"12680","DOI":"10.1038\/s41598-024-62820-7","volume":"14","author":"L Mosconi","year":"2024","unstructured":"Mosconi L, Nerattini M, Matthews DC, Jett S, Andy C, Williams S, Yepez CB, Zarate C, Carlton C, Fauci F, Ajila T (2024) In vivo brain estrogen receptor density by neuroendocrine aging and relationships with cognition and symptomatology. Sci Rep 14(1):12680","journal-title":"Sci Rep"},{"issue":"2","key":"1705_CR63","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00232-022-00225-1","volume":"255","author":"J Nah\u00e1lkov\u00e1","year":"2022","unstructured":"Nah\u00e1lkov\u00e1 J (2022) Finding new ways how to control BACE1. J Membrane Biol 255(2):293\u2013318","journal-title":"J Membrane Biol"},{"issue":"1","key":"1705_CR64","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s41512-024-00167-3","volume":"8","author":"T Nihashi","year":"2024","unstructured":"Nihashi T, Sakurai K, Kato T, Kimura Y, Ito K, Nakamura A, Terasawa T (2024) Blood levels of glial fibrillary acidic protein for predicting clinical progression to Alzheimer\u2019s disease in adults without dementia: a systematic review and meta-analysis protocol. Diagn Progn Res 8(1):4","journal-title":"Diagn Progn Res"},{"key":"1705_CR65","doi-asserted-by":"publisher","first-page":"112731","DOI":"10.1016\/j.bbr.2020.112731","volume":"393","author":"TPKRHMSRE O\u2019learyStoverMantolinoDarveshBrown","year":"2020","unstructured":"O\u2019learyStoverMantolinoDarveshBrown TPKRHMSRE (2020) Intact olfactory memory in the 5xFAD mouse model of Alzheimer\u2019s disease from 3 to 15 months of age. Behav Brain Res 393:112731","journal-title":"Behav Brain Res"},{"issue":"6","key":"1705_CR66","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1136\/jnnp-2021-328547","volume":"93","author":"P Oeckl","year":"2022","unstructured":"Oeckl P, Anderl-Straub S, Von Arnim CA, Baldeiras I, Diehl-Schmid J, Grimmer T, Halbgebauer S, Kort AM, Lima M, Marques TM, Ortner M (2022) Serum GFAP differentiates Alzheimer\u2019s disease from frontotemporal dementia and predicts MCI-to-dementia conversion. J Neurol, Neurosurg Psychiatr 93(6):659\u2013667","journal-title":"J Neurol, Neurosurg Psychiatr"},{"issue":"14","key":"1705_CR67","doi-asserted-by":"publisher","first-page":"e1474","DOI":"10.1212\/WNL.0000000000206833","volume":"100","author":"S Oveisgharan","year":"2023","unstructured":"Oveisgharan S, Yang J, Yu L, Burba D, Bang W, Tasaki S, Grodstein F, Wang Y, Zhao J, De Jager PL, Schneider JA (2023) Estrogen receptor genes, cognitive decline, and Alzheimer disease. Neurology 100(14):e1474\u2013e1487","journal-title":"Neurology"},{"key":"1705_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10408347.2024.2393874","volume":"16","author":"G Ozcelikay-Akyildiz","year":"2024","unstructured":"Ozcelikay-Akyildiz G, Karadurmus L, Cetinkaya A, Uludag \u0130, Ozcan B, Unal MA, Sezginturk MK, Ozkan SA (2024) The evaluation of clinical applications for the detection of the alzheimer\u2019s disease biomarker GFAP. Crit Rev Anal Chem 16:1\u20132","journal-title":"Crit Rev Anal Chem"},{"issue":"7","key":"1705_CR69","doi-asserted-by":"publisher","first-page":"630","DOI":"10.2174\/1570159X16666180926123722","volume":"17","author":"C Pe\u00f1a-Bautista","year":"2019","unstructured":"Pe\u00f1a-Bautista C, Baquero M, Vento M, Ch\u00e1fer-Peric\u00e1s C (2019) Omics-based biomarkers for the early Alzheimer disease diagnosis and reliable therapeutic targets development. Curr Neuropharmacol 17(7):630\u2013647","journal-title":"Curr Neuropharmacol"},{"issue":"12","key":"1705_CR70","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.1093\/brain\/awae211","volume":"147","author":"DE Peretti","year":"2024","unstructured":"Peretti DE, Boccalini C, Ribaldi F, Scheffler M, Marizzoni M, Ashton NJ, Zetterberg H, Blennow K, Frisoni GB, Garibotto V (2024) Association of glial fibrillary acid protein, Alzheimer\u2019s disease pathology and cognitive decline. Brain 147(12):4094\u20134104","journal-title":"Brain"},{"issue":"12","key":"1705_CR71","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1001\/jamaneurol.2024.3766","volume":"81","author":"RC Petersen","year":"2024","unstructured":"Petersen RC, Mormino E, Schneider JA (2024) Alzheimer disease\u2014what\u2019s in a name? JAMA Neurol 81(12):1245\u20131246","journal-title":"JAMA Neurol"},{"issue":"4","key":"1705_CR72","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3233\/JAD-141452","volume":"43","author":"I Piaceri","year":"2014","unstructured":"Piaceri I, Raspanti B, Tedde A, Bagnoli S, Sorbi S, Nacmias B (2014) Epigenetic modifications in Alzheimer\u2019s disease: cause or effect? J Alzheimer\u2019s Dis. 43(4):1169\u20131173","journal-title":"J Alzheimer\u2019s Dis."},{"key":"1705_CR73","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1007\/s12035-016-0357-6","volume":"55","author":"TJ Qazi","year":"2018","unstructured":"Qazi TJ, Quan Z, Mir A, Qing H (2018) Epigenetics in Alzheimer\u2019s disease: perspective of DNA methylation. Mol Neurobiol 55:1026\u20131044","journal-title":"Mol Neurobiol"},{"issue":"12","key":"1705_CR74","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.3390\/genes12121959","volume":"12","author":"R Rabaneda-Bueno","year":"2021","unstructured":"Rabaneda-Bueno R, Mena-Montes B, Torres-Castro S, Torres-Carrillo N, Torres-Carrillo NM (2021) Advances in genetics and epigenetic alterations in Alzheimer\u2019s disease: a notion for therapeutic treatment. Genes 12(12):1959","journal-title":"Genes"},{"issue":"3","key":"1705_CR75","doi-asserted-by":"publisher","first-page":"e4014","DOI":"10.1002\/cbf.4014","volume":"42","author":"E Rymbai","year":"2024","unstructured":"Rymbai E, Sugumar D, Chakkittukandiyil A, Kothandan R, Selvaraj D (2024) Molecular insights into the potential effects of selective estrogen receptor \u03b2 agonists in Alzheimer\u2019s and Parkinson\u2019s diseases. Cell Biochem Funct 42(3):e4014","journal-title":"Cell Biochem Funct"},{"issue":"13","key":"1705_CR76","doi-asserted-by":"publisher","first-page":"742242","DOI":"10.3389\/fnagi.2021.742242","volume":"25","author":"H Sabaie","year":"2021","unstructured":"Sabaie H, Amirinejad N, Asadi MR, Jalaiei A, Daneshmandpour Y, Rezaei O, Taheri M, Rezazadeh M (2021) Molecular insight into the therapeutic potential of long non-coding RNA-associated competing endogenous RNA axes in alzheimer\u2019s disease: a systematic scoping review. Front Aging Neurosci. 25(13):742242","journal-title":"Front Aging Neurosci."},{"issue":"6","key":"1705_CR77","first-page":"731","volume":"23","author":"O Saleh","year":"2024","unstructured":"Saleh O, Albakri K, Altiti A, Abutair I, Shalan S, Mohd OB, Negida A, Mushtaq G, Kamal MA (2024) The role of non-coding RNAs in Alzheimer\u2019s disease: pathogenesis, novel biomarkers, and potential therapeutic targets. CNS Neurol Disord-Drug Targets (Formerly Curr Drug Targets-CNS Neurol Disord) 23(6):731\u2013745","journal-title":"CNS Neurol Disord-Drug Targets (Formerly Curr Drug Targets-CNS Neurol Disord)"},{"key":"1705_CR78","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1111\/jnc.16086","volume":"168","author":"S Sarkar","year":"2024","unstructured":"Sarkar S, Pandey A, Yadav SK, Raghuwanshi P, Siddiqui MH, Srikrishna S, Pant AB, Yadav S (2024) MicroRNA-29b-3p degenerates terminally differentiated dopaminergic SH-SY5Y cells by perturbation of mitochondrial functions. J Neurochem 168:1297\u20131316","journal-title":"J Neurochem"},{"issue":"14","key":"1705_CR79","doi-asserted-by":"publisher","first-page":"1220150","DOI":"10.3389\/fendo.2023.1220150","volume":"4","author":"K Sato","year":"2023","unstructured":"Sato K, Takayama KI, Inoue S (2023) Expression and function of estrogen receptors and estrogen-related receptors in the brain and their association with Alzheimer\u2019s disease. Front Endocrinol 4(14):1220150","journal-title":"Front Endocrinol"},{"issue":"2","key":"1705_CR80","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S0304-3940(02)01481-7","volume":"339","author":"P Sch\u00f6nknecht","year":"2003","unstructured":"Sch\u00f6nknecht P, Pantel J, Hunt A, Volkmann M, Buerger K, Hampel H, Schr\u00f6der J (2003) Levels of total tau and tau protein phosphorylated at threonine 181 in patients with incipient and manifest Alzheimer\u2019s disease. Neurosci Lett 339(2):172\u2013174","journal-title":"Neurosci Lett"},{"issue":"16","key":"1705_CR81","doi-asserted-by":"publisher","first-page":"1477045","DOI":"10.3389\/fnagi.2024.1477045","volume":"13","author":"MR Schwabe","year":"2024","unstructured":"Schwabe MR, Fleischer AW, Kuehn RK, Chaudhury S, York JM, Sem DS, Donaldson WA, LaDu MJ, Frick KM (2024) The novel estrogen receptor beta agonist EGX358 and APOE genotype influence memory, vasomotor, and anxiety outcomes in an Alzheimer\u2019s mouse model. Front Aging Neurosci 13(16):1477045","journal-title":"Front Aging Neurosci"},{"issue":"9","key":"1705_CR82","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1038\/s41591-023-02505-2","volume":"29","author":"WK Self","year":"2023","unstructured":"Self WK, Holtzman DM (2023) Emerging diagnostics and therapeutics for Alzheimer disease. Nat Med 29(9):2187\u20132199","journal-title":"Nat Med"},{"issue":"2","key":"1705_CR83","doi-asserted-by":"publisher","first-page":"119","DOI":"10.37349\/ent.2024.00075","volume":"4","author":"S Selvam","year":"2024","unstructured":"Selvam S, Ayyavoo V (2024) Biomarkers in neurodegenerative diseases: a broad overview. Explor Neuroprotective Ther 4(2):119\u2013147","journal-title":"Explor Neuroprotective Ther"},{"issue":"5","key":"1705_CR84","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1215\/00703370-10941414","volume":"60","author":"S Sharma","year":"2023","unstructured":"Sharma S, Hale JM, Myrskyl\u00e4 M, Kulu H (2023) Racial, ethnic, nativity, and educational disparities in cognitive impairment and activity limitations in the United States, 1998\u20132016. Demography 60(5):1441\u20131468","journal-title":"Demography"},{"key":"1705_CR85","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1201\/9781032711102-3","volume-title":"Integrating neuroimaging, computational neuroscience, and artificial intelligence","author":"H Sharma","year":"2024","unstructured":"Sharma H, Singh AA, Singh AP (2024) A survey on machine learning applications in neuroimaging. Integrating neuroimaging, computational neuroscience, and artificial intelligence, 1st edn. CRC Press, pp 29\u201343","edition":"1"},{"issue":"4","key":"1705_CR86","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/clinchem\/hvad018","volume":"69","author":"XN Shen","year":"2023","unstructured":"Shen XN, Huang SY, Cui M, Zhao QH, Guo Y, Huang YY, Zhang W, Ma YH, Chen SD, Zhang YR, Chen SF (2023) Plasma glial fibrillary acidic protein in the Alzheimer disease continuum: relationship to other biomarkers, differential diagnosis, and prediction of clinical progression. Clin Chem 69(4):411\u2013421","journal-title":"Clin Chem"},{"issue":"3","key":"1705_CR87","doi-asserted-by":"publisher","first-page":"96","DOI":"10.14412\/2074-2711-2024-3-96-102","volume":"16","author":"KV Shevtsova","year":"2024","unstructured":"Shevtsova KV, Rozhkov DO, Grishina DA, Grinyuk VV, Zakharov VV, Kashakanova NM, Koberskaya NN, Kosivtsova OV, Lokshina AB, Starchina YA, Tyurina AY (2024) Biological markers of Alzheimer\u2019s disease in cerebrospinal fluid: clinical and laboratory comparisons. Neurol, Neuropsychiatr, Psychosomat 16(3):96\u2013102","journal-title":"Neurol, Neuropsychiatr, Psychosomat"},{"issue":"1","key":"1705_CR88","first-page":"e12291","volume":"14","author":"D Shir","year":"2022","unstructured":"Shir D, Graff-Radford J, Hofrenning EI, Lesnick TG, Przybelski SA, Lowe VJ, Knopman DS, Petersen RC, Jack CR Jr, Vemuri P, Algeciras-Schimnich A (2022) Association of plasma glial fibrillary acidic protein (GFAP) with neuroimaging of Alzheimer\u2019s disease and vascular pathology. Alzheimer\u2019s Dement: Diagn, Assess Dis Monit 14(1):e12291","journal-title":"Alzheimer's Dement: Diagn, Assess Dis Monit"},{"issue":"08","key":"1705_CR89","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1055\/a-1886-3208","volume":"72","author":"A Singh","year":"2022","unstructured":"Singh A, Ansari VA, Mahmood T, Ahsan F, Wasim R (2022) Dendrimers: A neuroprotective lead in alzheimer disease: a review on its synthetic approach and applications. Drug Res 72(08):417\u2013423","journal-title":"Drug Res"},{"issue":"09","key":"1705_CR90","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1055\/a-1915-4861","volume":"72","author":"A Singh","year":"2022","unstructured":"Singh A, Ansari VA, Mahmood T, Ahsan F, Wasim R (2022) Neurodegeneration: microglia: Nf-Kappab signaling pathways. Drug Res 72(09):496\u2013499","journal-title":"Drug Res"},{"issue":"05","key":"1705_CR91","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1055\/a-2052-8462","volume":"55","author":"A Singh","year":"2023","unstructured":"Singh A, Ansari VA, Ansari TM, Hasan SM, Ahsan F, Singh K, Wasim R, Maheshwari S, Ahmad A (2023) Consequence of dementia and cognitive impairment by primary nucleation pathway. Horm Metab Res 55(05):304\u2013314","journal-title":"Horm Metab Res"},{"issue":"05","key":"1705_CR92","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1055\/a-2015-8041","volume":"73","author":"A Singh","year":"2023","unstructured":"Singh A, Ansari VA, Mahmood T, Ahsan F, Wasim R, Shariq M, Parveen S, Maheshwari S (2023) Receptor for advanced glycation end products: dementia and cognitive impairment. Drug Research 73(05):247\u2013250","journal-title":"Drug Research"},{"issue":"8","key":"1705_CR93","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.52711\/0974-360X.2024.00568","volume":"17","author":"A Singh","year":"2024","unstructured":"Singh A, Ansari VA, Mahmood T (2024) Development and evaluation of ursolic acid loaded dendrimers. Res J Pharm Technol 17(8):3642\u20133648","journal-title":"Res J Pharm Technol"},{"key":"1705_CR94","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1055\/a-2238-1384","volume":"56","author":"A Singh","year":"2024","unstructured":"Singh A, Ansari VA, Mahmood T, Hasan SM, Wasim R, Maheshwari S, Akhtar J, Sheikh S, Vishwakarma VK (2024) Targeting abnormal tau phosphorylation for Alzheimer\u2019s therapeutics. Horm Metab Res 56:482\u2013488","journal-title":"Horm Metab Res"},{"issue":"3","key":"1705_CR95","doi-asserted-by":"publisher","first-page":"294","DOI":"10.2174\/0118715249289120240321065936","volume":"24","author":"A Singh","year":"2024","unstructured":"Singh A, Maheshwari S, Yadav JP, Varshney AP, Singh S, Prajapati BG (2024) A review on tau targeting biomimetics nano formulations: novel approach for targeting Alzheimer\u2019s diseases. Cent Nerv Syst Agents Med ChemChem-Cent Nerv Syst Agents 24(3):294\u2013303","journal-title":"Cent Nerv Syst Agents Med ChemChem-Cent Nerv Syst Agents"},{"issue":"7","key":"1705_CR96","doi-asserted-by":"publisher","first-page":"538","DOI":"10.2174\/0115734129300077240813063934","volume":"20","author":"A Singh","year":"2024","unstructured":"Singh A, Ansari VA, Ansari TM, Wasim R, Akhtar J, Maheshwari S (2024) Pharmacokinetic assessments of ursolic loaded-dendrimer complex. Curr Pharm Anal 20(7):538\u2013556","journal-title":"Curr Pharm Anal"},{"issue":"42","key":"1705_CR97","first-page":"1","volume":"1","author":"MA Smith","year":"1998","unstructured":"Smith MA (1998) Alzheimer disease. Int Rev Neurobiol 1(42):1\u201354","journal-title":"Int Rev Neurobiol"},{"issue":"3","key":"1705_CR98","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC (2011) Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the national institute on aging-alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimer\u2019s Dementia 7(3):280\u2013292","journal-title":"Alzheimer's Dementia"},{"issue":"1","key":"1705_CR99","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000264630","volume":"29","author":"N Striepens","year":"2010","unstructured":"Striepens N, Scheef L, Wind A, Popp J, Spottke A, Cooper-Mahkorn D, Suliman H, Wagner M, Schild HH, Jessen F (2010) Volume loss of the medial temporal lobe structures in subjective memory impairment. Dementia Geriatric Cognitive Disord 29(1):75\u201381","journal-title":"Dementia Geriatric Cognitive Disord"},{"key":"1705_CR100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12976-019-0118-0","volume":"17","author":"S Sundar","year":"2020","unstructured":"Sundar S, Battistoni C, McNulty R, Morales F, Gorky J, Foley H, Dhurjati P (2020) An agent-based model to investigate microbial initiation of Alzheimer\u2019s via the olfactory system. Theoreti Biol Med Modell. 17:1\u20135","journal-title":"Theoreti Biol Med Modell."},{"key":"1705_CR101","first-page":"1","volume":"12","author":"J Therriault","year":"2024","unstructured":"Therriault J, Janelidze S, Benedet AL, Ashton NJ, Arranz Mart\u00ednez J, Gonzalez-Escalante A, Bellaver B, Alcolea D, Vrillon A, Karim H, Mielke MM (2024) Diagnosis of Alzheimer\u2019s disease using plasma biomarkers adjusted to clinical probability. Nat Aging. 12:1\u20139","journal-title":"Nat Aging."},{"key":"1705_CR102","doi-asserted-by":"crossref","unstructured":"Tiwari A, Singh R, Kumar S, Sunkaria A, Jain A 2025. From Plant to Pathway: Molecular Mechanisms of Ruscogenin in Preventing Amyloid-Beta Aggregation through Computational and Experimental Approaches. ACS Chemical Neuroscience.","DOI":"10.1021\/acschemneuro.4c00745"},{"issue":"16","key":"1705_CR103","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1212\/WNL.0b013e3182a8418b","volume":"81","author":"AC van Harten","year":"2013","unstructured":"van Harten AC, Smits LL, Teunissen CE, Visser PJ, Koene T, Blankenstein MA, Scheltens P, van der Flier WM (2013) Preclinical AD predicts decline in memory and executive functions in subjective complaints. Neurology 81(16):1409\u20131416","journal-title":"Neurology"},{"issue":"8","key":"1705_CR104","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1161\/STROKEAHA.123.040499","volume":"54","author":"AC van Nieuwkerk","year":"2023","unstructured":"van Nieuwkerk AC, Delewi R, Wolters FJ, Muller M, Daemen M, Biessels GJ (2023) Heart-brain connection consortium. cognitive impairment in patients with cardiac disease: implications for clinical practice. Stroke 54(8):2181\u20132191","journal-title":"Stroke"},{"issue":"9","key":"1705_CR105","doi-asserted-by":"publisher","first-page":"4184","DOI":"10.3390\/s23094184","volume":"23","author":"AG Vrahatis","year":"2023","unstructured":"Vrahatis AG, Skolariki K, Krokidis MG, Lazaros K, Exarchos TP, Vlamos P (2023) Revolutionizing the early detection of Alzheimer\u2019s disease through non-invasive biomarkers: the role of artificial intelligence and deep learning. Sensors 23(9):4184","journal-title":"Sensors"},{"issue":"2","key":"1705_CR106","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3390\/endocrines4020020","volume":"4","author":"S Vujovi\u0107","year":"2023","unstructured":"Vujovi\u0107 S, Ivovi\u0107 M, Tan\u010di\u0107 Gaji\u0107 M, Marina L, Jovi\u010di\u0107 SP, Pavlovi\u0107 N, Jovi\u010di\u0107 ME (2023) Alzheimer\u2019s disease and premature ovarian insufficiency. Endocrines. 4(2):250\u2013256","journal-title":"Endocrines."},{"key":"1705_CR107","first-page":"1","volume":"1","author":"X Wang","year":"2024","unstructured":"Wang X, Feng S, Deng Q, Wu C, Duan R, Yang L (2024) The role of estrogen in Alzheimer\u2019s disease pathogenesis and therapeutic potential in women. Mol Cell Biochem 1:1\u20136","journal-title":"Mol Cell Biochem"},{"key":"1705_CR108","doi-asserted-by":"publisher","first-page":"162","DOI":"10.2174\/9789815238754124010011","volume-title":"Advances in diagnostics and immunotherapeutics for neurodegenerative diseases","author":"R Wasim","year":"2024","unstructured":"Wasim R, Mahmood T, Ahsan F, Singh A, Ahmad A (2024) Epigenetics as diagnostic and therapeutic tool in neurodegenerative disorders. Advances in diagnostics and immunotherapeutics for neurodegenerative diseases. Bentham Science Publishers, pp 162\u2013176"},{"issue":"105","key":"1705_CR109","doi-asserted-by":"publisher","first-page":"105573","DOI":"10.1016\/j.jff.2023.105573","volume":"1","author":"P Wei","year":"2023","unstructured":"Wei P, Li X, Gao H, Chen J, Lang W, Zeng L, Wei D, Chen M, Zhu Q, Jin G (2023) Olfactory stimulation from edible and medicinal homologous essential oils improves A\u03b2-induced cognitive impairment by regulating oxidative stress and synaptic function. J Funct Food. 1(105):105573","journal-title":"J Funct Food."},{"issue":"2","key":"1705_CR110","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1523\/JNEUROSCI.4622-09.2010","volume":"30","author":"DW Wesson","year":"2010","unstructured":"Wesson DW, Levy E, Nixon RA, Wilson DA (2010) Olfactory dysfunction correlates with amyloid-\u03b2 burden in an Alzheimer\u2019s disease mouse model. J Neurosci 30(2):505\u2013514","journal-title":"J Neurosci"},{"issue":"4","key":"1705_CR111","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.3390\/ijms24044043","volume":"24","author":"A Wnuk","year":"2023","unstructured":"Wnuk A, Przepi\u00f3rska K, Pietrzak BA, Kajta M (2023) Emerging evidence on membrane estrogen receptors as novel therapeutic targets for central nervous system pathologies. Int J Mol Sci 24(4):4043","journal-title":"Int J Mol Sci"},{"key":"1705_CR112","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.ncrna.2024.03.008","volume":"9","author":"X Wu","year":"2024","unstructured":"Wu X, Xia P, Yang L, Lu C, Lu Z (2024) The roles of long non-coding RNAs in Alzheimer\u2019s disease diagnosis, treatment, and their involvement in Alzheimer\u2019s disease immune responses. Non-Coding RNA Res 9:659\u2013666","journal-title":"Non-Coding RNA Res"},{"issue":"12","key":"1705_CR113","doi-asserted-by":"publisher","first-page":"5620","DOI":"10.1002\/alz.13318","volume":"19","author":"Y Yakoub","year":"2023","unstructured":"Yakoub Y, Ashton NJ, Strikwerda-Brown C, Montoliu-Gaya L, Karikari TK, Kac PR, Gonzalez-Ortiz F, Gallego-Rudolf J, Meyer PF, St-Onge F, Sch\u00f6ll M (2023) Longitudinal blood biomarker trajectories in preclinical Alzheimer\u2019s disease. Alzheimer\u2019s Dementia 19(12):5620\u20135631","journal-title":"Alzheimer's Dementia"},{"issue":"36","key":"1705_CR114","doi-asserted-by":"publisher","first-page":"e34982","DOI":"10.1097\/MD.0000000000034982","volume":"102","author":"X Yang","year":"2023","unstructured":"Yang X, Qu H (2023) Bibliometric review on biomarkers for Alzheimer\u2019s disease between 2000 and 2023. Medicine 102(36):e34982","journal-title":"Medicine"},{"issue":"14","key":"1705_CR115","doi-asserted-by":"publisher","first-page":"7789","DOI":"10.3390\/ijms23147789","volume":"23","author":"H Zhang","year":"2022","unstructured":"Zhang H, Liang J, Chen N (2022) The potential role of miRNA-regulated autophagy in Alzheimer\u2019s disease. Int J Mol Sci 23(14):7789","journal-title":"Int J Mol Sci"},{"key":"1705_CR116","doi-asserted-by":"publisher","first-page":"102485","DOI":"10.1016\/j.arr.2024.102485","volume":"4","author":"Y Zou","year":"2024","unstructured":"Zou Y, Wang Y, Ma X, Mu D, Zhong J, Ma C, Mao C, Yu S, Gao J, Qiu L (2024) CSF and blood glial fibrillary acidic protein for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis. Ageing Res Rev 4:102485","journal-title":"Ageing Res Rev"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01705-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01705-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01705-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T07:02:10Z","timestamp":1750230130000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01705-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":116,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["1705"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01705-1","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"3 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The authors declare no conflict of interest among themselves. The authors alone are responsible for the content and writing of this article. The authors declare they have no financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"NA.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not Applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}